SCHEMBL7804355

SCHEMBL7804355

CN1CCC(c2c[nH]c3ccc(CC4COC(=O)N4)cc23)CC1

nearest known ligand 0.70

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HTR1D P28221 14/20 0.70
▸ HTR1B P28222 14/20 0.70
▸ HTR1A P08908 6/20 0.69
▸ HTR1F P30939 2/20 0.69
▸ HTR2A P28223 3/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ ADRA1A P35348 1/20 0.57
▸ CYP1A2 P05177 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ CYP2C9 P11712 1/20 0.53
▸ THPO P40225 1/20 0.53
▸ APP P05067 1/20 0.51
▸ MAPT P10636 1/20 0.48
▸ BLM P54132 1/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9672029 1.00 HTR1D (0.70) HTR1DHTR1BHTR1AHTR1FHTR2A
Bromide SCHEMBL7810209 0.99 HTR1D (0.68) HTR1DHTR1BHTR1AHTR1FHTR2A
Bromide SCHEMBL7817539 0.99 HTR1D (0.68) HTR1DHTR1BHTR1AHTR1FHTR2A
Bromide SCHEMBL7810212 0.99 HTR1D (0.68) HTR1DHTR1BHTR1AHTR1FHTR2A
Bromide SCHEMBL7804661 0.85 HTR1D (0.72) HTR1DHTR1BHTR1AHTR1FHTR2A
Bromide SCHEMBL7804658 0.85 HTR1D (0.72) HTR1DHTR1BHTR1AHTR1FHTR2A
SCHEMBL8058259 0.82 HTR1D (1.00) HTR1DHTR1BHTR1AHTR1FHTR2A
SCHEMBL8058260 0.82 HTR1D (1.00) HTR1DHTR1BHTR1AHTR1FHTR2A
Naratriptan SCHEMBL6235276 0.82 HTR1D (0.64) HTR1DHTR1BHTR1AHTR1FHTR2A
SCHEMBL8067580 0.82 HTR1D (1.00) HTR1DHTR1BHTR1AHTR1FHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0636623-B1 Indole derivatives as 5-HT1- like agonists ASTRAZENECA AB (SE) 2001-08-16 — — EP claimed
EP-0636623-A1 Indole derivatives as 5-HT1- like agonists THE WELLCOME FOUNDATION LIMITED (GB) 1995-02-01 — — EP claimed
EP-0486666-A1 THERAPEUTIC HETEROCYCLIC COMPOUNDS. WELLCOME FOUND (GB) 1992-05-27 — — EP claimed
WO-1991018897-A1 THERAPEUTIC HETEROCYCLIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-12 — — WO claimed
EP-0636623-B1 Indole derivatives as 5-HT1- like agonists ASTRAZENECA AB (SE) 2001-08-16 — — EP disclosed
US-5863935-A SYNTHESIS OF INDOLE DERIVATIVES OF HETEROCYCLIC COMPOUNDS FOR TREATMENT OF HEADACHES AND MIGRAINES ZENECA LIMITED (GB) 1999-01-26 — — US disclosed
EP-0486666-B1 THERAPEUTIC HETEROCYCLIC COMPOUNDS ZENECA LTD (GB) 1997-08-13 — — EP disclosed
US-5466699-A Indolyl compounds for treating migraine BURROUGHS WELLCOME CO. (US) 1995-11-14 — — US disclosed
US-5399574-A 5-hydroxytryptamine agonists; vasoconstrictors BURROUGHS WELLCOME CO. (US) 1995-03-21 — — US disclosed
EP-0636623-A1 Indole derivatives as 5-HT1- like agonists THE WELLCOME FOUNDATION LIMITED (GB) 1995-02-01 — — EP disclosed
EP-0486666-A1 THERAPEUTIC HETEROCYCLIC COMPOUNDS. WELLCOME FOUND (GB) 1992-05-27 — — EP disclosed
WO-1991018897-A1 THERAPEUTIC HETEROCYCLIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-12 — — WO disclosed
Send feedback